Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells

Pharmacological inhibition of microsomal prostaglandin E synthase (mPGES)-1 for selective reduction in prostaglandin E(2) (PGE(2)) biosynthesis is protective in experimental models of cancer and inflammation. Targeting mPGES-1 is envisioned as a safer alternative to traditional non-steroidal anti-in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergqvist, Filip, Ossipova, Elena, Idborg, Helena, Raouf, Joan, Checa, Antonio, Englund, Karin, Englund, Petter, Khoonsari, Payam Emami, Kultima, Kim, Wheelock, Craig E., Larsson, Karin, Korotkova, Marina, Jakobsson, Per-Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567928/
https://www.ncbi.nlm.nih.gov/pubmed/31231223
http://dx.doi.org/10.3389/fphar.2019.00636

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567928/
https://www.ncbi.nlm.nih.gov/pubmed/31231223
http://dx.doi.org/10.3389/fphar.2019.00636

Ejemplares similares